Gaelle E Doucet1, David C Glahn2, Sophia Frangou3. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Boys Town National Research Hospital, Omaha, NE, United States. 2. Tommy Fuss Center for Neuropsychiatric Disease Research, Boston Children's Hospital, Boston, Harvard University, MA, United States. 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Centre for Brain Health, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. Electronic address: sophia.frangou@mssm.edu.
Abstract
BACKGROUND: Bipolar disorder shows significant variability in clinical presentation. Here we adopt a personalized approach to quantify the brain structural and functional similarity of each individual patient to other patients and to healthy individuals. METHODS: Brain morphometric and resting-state functional connectivity measures from two independent samples of patients with bipolar disorder and healthy individuals (total number of participants=215) were modeled as single vectors to generated individualized morphometric and connectivity profiles. These profiles were then used to compute a person-based similarity indices which quantified the similarity in neuroimaging profiles amongst patients and between patients and health individuals. RESULTS: The morphometric and connectivity profiles of patients showed within-diagnosis similarity which was comparable to that observed in healthy individuals. They also showed minimal deviance from those of healthy individuals; the correlation between the profiles of patients and healthy individuals was high (range: 0.71-0.94, p<10-5). The degree of similarity between imaging profiles was associated with IQ (for cortical thickness) and age (functional integration) rather than clinical variables. Patients who were prescribed lithium, compared to those who were not, showed greater similarity to healthy individuals in terms of network integration (t = 2.2, p = 0.03). LIMITATIONS: We focused on patients with Bipolar disorder, type I only. CONCLUSIONS: High inter-individual similarity in neuroimaging profiles was observed amongst patients with bipolar disorder and between patients and healthy individuals. We infer that brain alterations associated with bipolar disorder may be nested within the normal biological diversity consistent with the high prevalence of mood symptoms in the general population.
BACKGROUND:Bipolar disorder shows significant variability in clinical presentation. Here we adopt a personalized approach to quantify the brain structural and functional similarity of each individual patient to other patients and to healthy individuals. METHODS: Brain morphometric and resting-state functional connectivity measures from two independent samples of patients with bipolar disorder and healthy individuals (total number of participants=215) were modeled as single vectors to generated individualized morphometric and connectivity profiles. These profiles were then used to compute a person-based similarity indices which quantified the similarity in neuroimaging profiles amongst patients and between patients and health individuals. RESULTS: The morphometric and connectivity profiles of patients showed within-diagnosis similarity which was comparable to that observed in healthy individuals. They also showed minimal deviance from those of healthy individuals; the correlation between the profiles of patients and healthy individuals was high (range: 0.71-0.94, p<10-5). The degree of similarity between imaging profiles was associated with IQ (for cortical thickness) and age (functional integration) rather than clinical variables. Patients who were prescribed lithium, compared to those who were not, showed greater similarity to healthy individuals in terms of network integration (t = 2.2, p = 0.03). LIMITATIONS: We focused on patients with Bipolar disorder, type I only. CONCLUSIONS: High inter-individual similarity in neuroimaging profiles was observed amongst patients with bipolar disorder and between patients and healthy individuals. We infer that brain alterations associated with bipolar disorder may be nested within the normal biological diversity consistent with the high prevalence of mood symptoms in the general population.
Authors: David M Gardner; Andrea L Murphy; Heather O'Donnell; Franca Centorrino; Ross J Baldessarini Journal: Am J Psychiatry Date: 2010-04-01 Impact factor: 18.112
Authors: Gaelle E Doucet; Danielle S Bassett; Nailin Yao; David C Glahn; Sophia Frangou Journal: Am J Psychiatry Date: 2017-08-18 Impact factor: 18.112
Authors: Pauline Favre; Melissa Pauling; Jacques Stout; Franz Hozer; Samuel Sarrazin; Christoph Abé; Martin Alda; Clara Alloza; Silvia Alonso-Lana; Ole A Andreassen; Bernhard T Baune; Francesco Benedetti; Geraldo F Busatto; Erick J Canales-Rodríguez; Xavier Caseras; Tiffany Moukbel Chaim-Avancini; Christopher R K Ching; Udo Dannlowski; Michael Deppe; Lisa T Eyler; Mar Fatjo-Vilas; Sonya F Foley; Dominik Grotegerd; Tomas Hajek; Unn K Haukvik; Fleur M Howells; Neda Jahanshad; Harald Kugel; Trine V Lagerberg; Stephen M Lawrie; Julia O Linke; Andrew McIntosh; Elisa M T Melloni; Philip B Mitchell; Mircea Polosan; Edith Pomarol-Clotet; Jonathan Repple; Gloria Roberts; Annerine Roos; Pedro G P Rosa; Raymond Salvador; Salvador Sarró; Peter R Schofield; Mauricio H Serpa; Kang Sim; Dan J Stein; Jess E Sussmann; Henk S Temmingh; Paul M Thompson; Norma Verdolini; Eduard Vieta; Michele Wessa; Heather C Whalley; Marcus V Zanetti; Marion Leboyer; Jean-François Mangin; Chantal Henry; Edouard Duchesnay; Josselin Houenou Journal: Neuropsychopharmacology Date: 2019-08-21 Impact factor: 7.853
Authors: Delfina Janiri; Dominik A Moser; Gaelle E Doucet; Maxwell J Luber; Alexander Rasgon; Won Hee Lee; James W Murrough; Gabriele Sani; Simon B Eickhoff; Sophia Frangou Journal: JAMA Psychiatry Date: 2020-02-01 Impact factor: 21.596
Authors: Helen Baldwin; Joaquim Radua; Mathilde Antoniades; Shalaila S Haas; Sophia Frangou; Ingrid Agartz; Paul Allen; Ole A Andreassen; Kimberley Atkinson; Peter Bachman; Inmaculada Baeza; Cali F Bartholomeusz; Michael W L Chee; Tiziano Colibazzi; Rebecca E Cooper; Cheryl M Corcoran; Vanessa L Cropley; Bjørn H Ebdrup; Adriana Fortea; Louise Birkedal Glenthøj; Holly K Hamilton; Kristen M Haut; Rebecca A Hayes; Ying He; Karsten Heekeren; Michael Kaess; Kiyoto Kasai; Naoyuki Katagiri; Minah Kim; Jochen Kindler; Mallory J Klaunig; Shinsuke Koike; Alex Koppel; Tina D Kristensen; Yoo Bin Kwak; Jun Soo Kwon; Stephen M Lawrie; Irina Lebedeva; Jimmy Lee; Ashleigh Lin; Rachel L Loewy; Daniel H Mathalon; Chantal Michel; Romina Mizrahi; Paul Møller; Barnaby Nelson; Takahiro Nemoto; Dorte Nordholm; Maria A Omelchenko; Christos Pantelis; Jayachandra M Raghava; Jan I Røssberg; Wulf Rössler; Dean F Salisbury; Daiki Sasabayashi; Ulrich Schall; Lukasz Smigielski; Gisela Sugranyes; Michio Suzuki; Tsutomu Takahashi; Christian K Tamnes; Jinsong Tang; Anastasia Theodoridou; Sophia I Thomopoulos; Alexander S Tomyshev; Peter J Uhlhaas; Tor G Værnes; Therese A M J van Amelsvoort; Theo G M Van Erp; James A Waltz; Lars T Westlye; Stephen J Wood; Juan H Zhou; Philip McGuire; Paul M Thompson; Maria Jalbrzikowski; Dennis Hernaus; Paolo Fusar-Poli Journal: Transl Psychiatry Date: 2022-07-26 Impact factor: 7.989
Authors: Emilio Bergamelli; Lorenzo Del Fabro; Giuseppe Delvecchio; Armando D'Agostino; Paolo Brambilla Journal: CNS Drugs Date: 2021-11-12 Impact factor: 6.497